VETREI, CINZIA

VETREI, CINZIA  

Mostra records
Risultati 1 - 10 di 10 (tempo di esecuzione: 0.014 secondi).
Titolo Tipologia Data di pubblicazione Autore(i) File
Ipilimumab and Its Derived EGFR Aptamer-Based Conjugate Induce Efficient NK Cell Activation against Cancer Cells. 1.1 Articolo in rivista 2020 Passariello, M; Camorani, S; Vetrei, C; Ricci, S; Cerchia, L; De Lorenzo, C
Novel Human Bispecific Aptamer-Antibody Conjugates for Efficient Cancer Cell Killing 1.1 Articolo in rivista 2019 Passariello, M; Camorani, S; Vetrei, Cinzia; Cerchia, L; De Lorenzo, C.
Novel Human Anti-PD-L1 mAbs Inhibit Immune-Independent Tumor Cell Growth and PD-L1 Associated Intracellular Signalling 1.1 Articolo in rivista 2019 Passariello, M; D'Alise, Am; Esposito, A; Vetrei, C; Froechlich, Guendalina; Scarselli, E; Nicosia, A; De Lorenzo, C.
Evidence that PP2A activity is dispensable for spindle assembly checkpoint-dependent control of Cdk1 1.1 Articolo in rivista 2018 Cervone, N; Monica, R. D.; Serpico, A. F.; Vetrei, C; Scaraglio, M; Visconti, R; Grieco, Domenico
Wee1 rather than plk1 is inhibited by AZD1775 at therapeutically relevant concentrations 1.1 Articolo in rivista 2019 Serpico, A. F.; D'Alterio, G.; Vetrei, C.; Monica, R. D.; Nardella, L.; Visconti, R.; Grieco, D.
Isolation of Two Novel Human Anti-CTLA-4 mAbs with Intriguing Biological Properties on Tumor and NK Cells 1.1 Articolo in rivista 2020 Passariello, M; Vetrei, C; Sasso, E; Froechlich, G; Gentile, C; D'Alise, Am; Zambrano, N; Scarselli, E; Nicosia, A; De Lorenzo, C.
Novel human neutralizing mAbs specific for Spike-RBD of SARS-CoV-2 1.1 Articolo in rivista 2021 Passariello, M.; Gentile, C.; Ferrucci, V.; Sasso, E.; Vetrei, C.; Fusco, G.; Viscardi, M.; Brandi, S.; Cerino, P.; Zambrano, N.; Zollo, M.; De Lorenzo, C.
Interactions of spike‐rbd of sars‐cov‐2 and platelet factor 4: New insights in the etiopathogenesis of thrombosis 1.1 Articolo in rivista 2021 Passariello, M.; Vetrei, C.; Amato, F.; De Lorenzo, C.
Immunomodulatory mabs as tools to investigate on cis-interaction of pd-1/pd-l1 on tumor cells and to set up methods for early screening of safe and potent combinatorial treatments 1.1 Articolo in rivista 2021 Vetrei, C.; Passariello, M.; Froechlich, G.; Lembo, R. R.; Zambrano, N.; De Lorenzo, C.
Novel combinations of human immunomodulatory mAbs lacking cardiotoxic effects for therapy of TNBC 1.1 Articolo in rivista 2022 Vetrei, C.; Passariello, M.; Froechlich, G.; Lembo, R. R.; Sasso, E.; Zambrano, N.; De Lorenzo, C.